JACC: CardioOncology - Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients with Transthyretin Amyloid Cardiomyopathy | JACC Specialty Journals | lystn | Audio Stories, Podcasts, Originals

JACC: CardioOncology - Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients with Transthyretin Amyloid Cardiomyopathy

Commentary by Dr. Martha Grogan

2356 232

JACC: CardioOncology - Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients with Transthyretin Amyloid Cardiomyopathy3 years ago

03:57

Suggested Podcasts

Level Up! with Naser

ASCO Guidelines

Could It Be Oak Island Podcast

The Riverdale After Show Podcast

Business Lunch

المصحف المرتل 1433 هـ - ناصر القطامي

That Sounds Fun with Annie F. Downs

The Fluent Nerd

Tales of the Trade

Sajiu

Download the app

Get it on Google Play Available on the App Store

PRIVACY POLICY | TERMS AND CONDITIONS

lystn.fm © 2024.
ALL RIGHTS RESERVED. CONTENT IS COPYRIGHT OF RESPECTIVE CONTENT OWNERS. | NX Digital FZ LLC & Tellyfonic Digital Media